Who is the best eye doctor in Zurich? In Switzerland? In the world? While such questions are inherently subjective, peer recognition provides a meaningful benchmark.
Medical trade journal, The Ophthalmologist seeks to answer this by publishing its biennial Power List—a global selection of the 100 most influential individuals shaping the future of ophthalmology.
The ELZA Institute is proud to announce that Prof. Kaweh Mansouri has been included in The Ophthalmologist’s “Power List” for the third time.
The Ophthalmologist’s “CXL: What’s New in 2023?” article explores advancements in corneal collagen crosslinking for treating keratoconus. ELZA’s Farhad Hafezi discusses how CXL has advanced to the current state of the art, and highlights new breakthroughs like sub400 and PACE.
POWER LIST 2023. Who is the best eye doctor in Zurich? Who is the best eye doctor in Switzerland? In the world? It’s not
Prof. Farhad Hafezi, MD, PhD, FARVO is the Medical Director at The ELZA Institute, was recently interviewed by Ocular Surgery News (OSN), where he spoke about advancing CXL technology for the treatment of corneal ectasias like keratoconus. The interview covered three main topics.
Prof. Farhad Hafezi was recently profiled in the Swiss newspaper, Limmattaler Zeitung, in which he discussed everything from his pioneering research into corneal cross-linking (CXL), how he has spent the last two decades improving CXL to better treat not just keratoconus, but infections of the cornea too – in a way that doesn’t require antibiotics or antifungal drugs to kill the infectious organisms.
We at the ELZA Institute are proud to report that our landmark paper that describes how the sub400 protocol is used to perform CXL in
“COVID-19 cannot prevent us from sharing important knowledge about oculofacical plastic surgery”, says Dr. Dion Paridaens, the ELZA Institute’s Consultant Oculofacial plastic surgeon. Dr. Paridaens
And so, at this year’s annual meeting of the European Society for Cataract and Refractive Surgery (ESCRS 2020), held online from 2–4 October 2020, a poster, presented by Dr. Emilio Torres-Netto, entitled “Corneal cross-linking for treating infectious keratitis: final results of the prospective randomized controlled multicentre trial” took first place in the Refractive Surgery category. The phase III trial results showed that corneal ulcers can be treated just as effectively with PACK-CXL as with the latest antibiotics, something that will soon become increasingly important.
